Form D · Pharmaceuticals
Persist AI Formulations Corp
Woodland, CA · CIK 0001974261
Offering snapshot reported Apr 24, 2023 · SEC filing
- Reported sold
- $4.89M Offering amount: $5.47M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 13, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2023 | Initial | $4,888,484 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479811
Simple Agreements for Future Equity
Source: Form D, filed Apr 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karthik Raman | Director, Executive |
| Christopher Shelner | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1100 Main Street Suite 300 Pb
Woodland, CA, 95695
Woodland, CA, 95695